eLearning: Module 2–Development of Small Molecule Therapeutics for CNS Diseases

When:  Mar 21, 2024 from 11:00 AM to 12:30 PM (ET)
Associated with  ACTalks

The American College of Toxicology is proud to offer a new eLearning Seminar focused on development of CNS/Neurology Therapeutics. These four modules are intended to provide insight into the development of therapeutics for CNS/Neurology diseases, focusing on the regulatory and nonclinical considerations for safety assessment of therapies encompassing standard and novel modalities, including small molecules, biologics, anti-sense oligonucleotides (ASOs)/miRNA, and advanced cell and gene therapies.

Module 1: Regulatory Considerations for the Development of CNS/Neurology Therapeutics 
Module 2: Development of Small Molecule Therapeutics for CNS Diseases
Module 3: Development of Advanced CNS/Neurology Therapeutics
Module 4: Development of Biologics for CNS Diseases

For more information and registration, please visit: ACT eLearning



Buay Permpoontaweesup
(703) 547-0875 (1402)